Attached files
file | filename |
---|---|
EX-99.1 - EX-99.1 - Cardiac Science CORP | v56450exv99w1.htm |
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
the Securities Exchange Act of 1934
July 29, 2010
Date of Report (Date of earliest event reported)
CARDIAC SCIENCE CORPORATION
Delaware | 000-51512 | 94-3300396 | ||
(State or Other Jurisdiction | (Commission File No.) | (IRS Employer | ||
of Incorporation) | Identification No.) |
3303 Monte Villa Parkway, Bothell, Washington | 98021 | |
(Address of Principal Executive Offices) | (Zip Code) |
(425) 402-2000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions:
o Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
TABLE OF CONTENTS
Item 2.02. Results of Operations and Financial Condition | ||||||||
Item 9.01. Financial Statements and Exhibits | ||||||||
SIGNATURE | ||||||||
INDEX TO EXHIBITS | ||||||||
EX-99.1 |
Table of Contents
Item 2.02. Results of Operations and Financial Condition.
On July 29, 2010 Cardiac Science Corporation issued its earnings release announcing its
financial results for the three and six months ended June 30, 2010. A copy of the earnings release is
attached hereto as Exhibit 99.1 and is incorporated herein by reference.
The information furnished under Item 2.02 of this Current Report on Form 8-K, including the
exhibit attached hereto, shall not be deemed to be filed for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that
section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of
1933, except as expressly set forth by specific reference in such filing.
Some statements in this Current Report on Form 8-K are forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not
guarantees of future actions and actual actions may vary materially from those expressed or implied
in such statements. For information on certain factors that may affect future actions and results,
please see our public filings with the Securities and Exchange Commission, including our most
recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
99.1 Earnings release of Cardiac Science Corporation dated July 29, 2010.
Table of Contents
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the
registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly
authorized.
CARDIAC SCIENCE CORPORATION |
||||
By: | /s/ Michael K. Matysik | |||
Michael K. Matysik | ||||
Senior Vice President and Chief Financial Officer | ||||
Dated: July 29, 2010
Table of Contents